Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.

PLoS One · 2012 · PMC3485195 · PMID 23118945

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp = 0.1so close (0.05 < p ≤ 0.1)

Compared to the patients in the low Lp-PLA2 activity group those in the high Lp-PLA2 activity group showed a trend toward worse CV death- (81.4% vs. 91.6%, p = 0.1) and AMI-free survival (81.2% vs. 91.5%, p = 0.07), but significantly worse CV event- (66.7% vs. 79.5%, p = 0.023) and ACS event-free survival (75.4% vs. 85.6%, p = 0.04) ( Figure 4 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.